P3 Health Partners Inc. (PIII)

NEUTRAL

HealthcareMedical Care FacilitiesUnited States

Fundamental

मूल्य

$10.07

मार्केट कैप

$2.04B

Yahoo Finance TradingView समाचार वेबसाइट

भाग 1 · कंपनी का मूल्य कितना है

अवलोकन

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

बैलेंस शीट और तरलता

राजस्व

$1.50B

पिछले 12 महीने (30/6/2026 तक)

शुद्ध आय

$-98M

पिछले 12 महीने (30/6/2026 तक)

Free Cash Flow

कुल इक्विटी

$-155M

कुल देनदारियाँ

$797M

Current Ratio

0.46

Interest Coverage

2.44

Debt/EBITDA

Earnings Per Share

राजस्व और शुद्ध आय

Free Cash Flow

आय विवरण

ऐतिहासिक विवरण

समय के साथ मार्जिन

समय के साथ ऋण

ऋण कितना भारी है

वृद्धि तालिका

वृद्धि — राजस्व

Fair Value अनुमान

General caseकम मूल्यांकित

Fair Value

$18.00

वर्तमान मूल्य

$10.07

Margin of Safety

+44.1%

Fair Value सीमा

$17.10 - $18.90

अनुमान विधियाँ

Analyst price target:$18.00

Discounted cash flow (DCF):Not enough data to compute it

Earnings multiple (P/E):Not enough data to compute it

Graham growth formula:Not enough data to compute it

Earnings power value (EPV):Not enough data to compute it

Justified P/B:$15.59

Dividend discount (Gordon):Not enough data to compute it

P/FFO, funds from operations:Not enough data to compute it

Mid-cycle earnings:Not enough data to compute it

Revenue multiple:Not enough data to compute it

विश्लेषक सहमति:दृढ़ खरीदें (6B / 2H / 0S)

अंतिम Earnings सरप्राइज़:+67.41%

मूल्यांकन मेट्रिक्स

P/E Ratio

ROE

95.3%

P/B Ratio

0.54

P/FCF

Gross Margin

ROIC

-44.2%

लाभप्रदता Radar

Value Creation (Economic Moat)

ROIC

-44.2%

WACC

14.7%

ROIC − WACC

-58.9 pp

ROIC is below the cost of capital — the company is destroying value for every dollar invested.

Fundamental विश्लेषण मानदंड

पास (6)

P/B Ratio 0.54
Interest Coverage
ROE 10.3%
Revenue Growth 5Y 24.6%
Analyst Consensus 75% Buy
Net Margin Trend -6.6% vs -10.0%

फेल (11)

EPS shows upward trend
Price CAGR -50.65%
ROIC -44.2%
Operating Margin -9.9%
Current Ratio
Return on Tangible Assets
Low reliance on intangibles
DCF valuation (Unknown)
Earnings Surprise avg -4.8%
Share Dilution 30.1%
Piotroski F-Score 2/9

अनुपलब्ध (10)

Gross Margin NaN%
P/FCF NaN
Dividend Payout NaN%
Debt/Equity ratio
Positive Free Cash Flow
CapEx intensity
Debt/EBITDA
Price below Graham Number
PEG Ratio (need PE > 0 and growth > 0)
Earnings Quality (OCF/Net Income)

Piotroski F-Score

2/9

गंभीर वित्तीय चिंताएं

score

criteria

Earnings गुणवत्ता

निम्न गुणवत्ता: accounting की जांच करें

शेयर Dilution

30.1%

नए शेयर जारी कर रही है, स्वामित्व को कम कर रही है

प्रशासन

कार्यकारी टीम

नाम	पद	आयु
Dr. Aric Coffman M.D.	CEO, President & Director	51
Dr. Amir Bacchus M.B.A., M.D.	Co-Founder, Chief Medical Officer & Director	60
Mr. Leif Pedersen	Chief Financial Officer	49
Mr. William Bettermann	Executive VP & COO	-
Mr. Devery Goodey	Senior Vice President of Technology	-
Ms. Sarah Bussmann B.S.N., CRNI, M.H.A., R.N.	Chief Administrative Officer	-

भाग 2 · कीमत और खरीदने का समय

यह हिस्सा यह नहीं बताता कि कंपनी अच्छी है या नहीं: यह तय करने में मदद करता है कि उसे कब खरीदें, जब फंडामेंटल आपको आश्वस्त कर चुके हों। इसमें: तकनीकी विश्लेषण, संभावना, ऐतिहासिक गिरावट, गामा एक्सपोज़र।

Latest News

Recent headlines for PIII, sourced from Markets Gazette.

No recent news for PIII.